Literature DB >> 8895741

Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.

M A Shibata1, J M Ward, D E Devor, M L Liu, J E Green.   

Abstract

The progression of prostatic intraepithelial neoplasia (PIN) to invasive prostate carcinoma has been analyzed in the C3(1)/T(AG) transgenic mouse model and appears very similar to the process proposed to occur in humans. PIN lesions in these transgenic mice histologically resemble those found in human PIN. Low-grade PIN was observed in the ventral and dorsolateral lobes at 2 months of age, whereas high-grade PIN was found in both lobes by 5 months of age. A progressive increase in the number of PIN lesions was observed with age. Prostate carcinomas, which appeared to arise from PIN lesions, were found by 7 months of age in the ventral lobe and 11 months of age in the dorsolateral lobe. Expression of T(AG) mRNA and protein in these lesions correlated with the development of PIN and carcinomas, as did the overexpression of p53 protein. Apoptosis levels were quite low in normal epithelial cells, moderate in low-grade PIN, and high in high-grade PIN and carcinomas. Levels of expression of proliferating cell nuclear antigen correlated with the degree of severity of the prostate lesions. Eighteen % of PIN lesions were found to already harbor Ha-ras mutations, whereas 33% of carcinomas showed various mutations in Ha-ras, Ki-ras, and/or p53. Mutations in Ha-ras may, therefore, be an early event in a significant portion of PIN lesions. Because high-grade PIN showed many characteristics similar to those observed in carcinomas and high-grade PIN was often found contiguous to carcinomas, we conclude that high-grade PIN is a precursor lesion of prostate carcinoma in this transgenic model. These transgenic mice will be useful to study mechanisms responsible for the progression of invasive carcinomas from PIN precursor lesions, as may occur during the development of prostate cancer in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895741

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.

Authors:  M J Tevethia; R H Bonneau; J W Griffith; L Mylin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.

Authors:  Tetsuro Watabe; Mark Lin; Hisamitsu Ide; Annemarie A Donjacour; Gerald R Cunha; Owen N Witte; Robert E Reiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

Authors:  E M Garabedian; P A Humphrey; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.

Authors:  J DiGiovanni; K Kiguchi; A Frijhoff; E Wilker; D K Bol; L Beltrán; S Moats; A Ramirez; J Jorcano; C Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

5.  Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model.

Authors:  Veda Diwadkar-Navsariwala; Gail S Prins; Steven M Swanson; Lynn A Birch; Vera H Ray; Samad Hedayat; Daniel L Lantvit; Alan M Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

6.  Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression.

Authors:  Colin R Soares; Masa-Aki Shibata; Jeffrey E Green; Cheryl L Jorcyk
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

7.  Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.

Authors:  Sarki A Abdulkadir; Jeffrey A Magee; Thomas J Peters; Zahid Kaleem; Cathy K Naughton; Peter A Humphrey; Jeffrey Milbrandt
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Prostatic intraepithelial neoplasia in genetically engineered mice.

Authors:  Jae-Hak Park; Judy E Walls; Jose J Galvez; Minjung Kim; Cory Abate-Shen; Michael M Shen; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 9.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

10.  Physical activity reduces prostate carcinogenesis in a transgenic model.

Authors:  Karyn A Esser; Clifford E Harpole; Gail S Prins; Alan M Diamond
Journal:  Prostate       Date:  2009-09-15       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.